Europe, U.S., and India Liquid Biopsy Market Booming with Rapid Growth Through 2033 | Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc

California, August 2026 - According to CMI, The Europe, U.S., and India liquid biopsy market is expected to grow from USD 169.2 Mn in 2026 to USD 535.2 Mn by 2033, registering a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.

The Europe, U.S., and India Liquid Biopsy Market (2026-2033) research report delivers comprehensive global, regional, and country-level market intelligence, offering reliable forecasts, competitive benchmarking, and strategic business insights. The study evaluates current market performance, emerging growth opportunities, evolving industry trends, and technological advancements that are expected to shape the market through 2033. It also examines investment potential, supply chain developments, regulatory influences, and market dynamics to help businesses make informed strategic decisions.

Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/9893

The report provides a detailed assessment of key market drivers, growth restraints, emerging opportunities, competitive developments, and industry challenges. Supported by SWOT analysis, market intelligence, and data-driven research methodologies, the study enables stakeholders to understand the evolving business landscape and identify profitable growth areas across the Europe, U.S., and India Liquid Biopsy Market.

Market Top Companies Covered In This Report:

◘ F. Hoffmann-La Roche Ltd.
◘ Guardant Health Inc.
◘ Illumina Inc.
◘ QIAGEN N.V.
◘ Thermo Fisher Scientific Inc.
◘ Exact Sciences Corporation
◘ Bio-Rad Laboratories Inc.
◘ Natera Inc.
◘ Myriad Genetics Inc.
◘ Menarini Silicon Biosystems S.p.A

Market Segmentation:

◘ By Type: Assay/Kits, Instruments, Services and Software, and Accessories and Consumables
◘ By Biomarker Type: CtDNA, CTCs, Extracellular Vesicles (EVS), and Others
◘ By Disease Indication: Lung Cancer, Gastrointestinal Cancer, Prostate Cancer, Breast Cancer, Skin Cancer, Colorectal Cancer, Bladder Cancer, Liver Cancer, and Others
◘ By Application: Detection/Screening, Therapy Selection, and Treatment Monitoring
◘ By End User: Hospitals, Cancer Institutes, Academic and Research Institutes, Diagnostic Centers/Laboratories, and Others

Get an Exclusive Sample Copy of the Report at: https://www.coherentmarketinsights.com/insight/request-sample/9893

Research Methodology:

This market research report is based on a structured research framework that combines both primary and secondary research methodologies. Industry experts, senior executives, manufacturers, distributors, and market participants were interviewed to validate market trends, competitive developments, and future growth opportunities.

Secondary research includes analysis of annual reports, company publications, investor presentations, government databases, regulatory documents, industry journals, trade associations, and other credible public sources. The collected data is carefully verified through multiple validation processes to ensure high accuracy, consistency, and reliability. This comprehensive research methodology provides actionable insights into market size, growth potential, competitive positioning, demand-supply dynamics, and future industry outlook.

Important Points for Europe, U.S., and India Liquid Biopsy Market Analysis:

✅ Market Players & Competitive Landscape: The report profiles leading companies by analyzing product portfolios, business strategies, production capacity, pricing, revenue, gross margins, recent developments, and competitive positioning to provide a comprehensive view of the market landscape.
✅ Regional Market Assessment: Detailed market analysis across major regions and countries includes revenue forecasts, market share, demand trends, sales performance, and growth opportunities segmented by product type and application.
✅ Industry Trends: The report highlights major market trends, digital transformation, product innovation, sustainability initiatives, strategic collaborations, mergers & acquisitions, and evolving customer preferences influencing market growth.
✅ Growth Drivers & Opportunities: The study identifies key demand drivers, technological innovations, investment opportunities, regulatory developments, and emerging business segments expected to accelerate market expansion.
✅ Porter's Five Forces Analysis: Comprehensive evaluation of industry competitiveness based on supplier bargaining power, buyer bargaining power, competitive rivalry, threat of substitutes, and barriers to new market entrants.

Buy this report and Get Up to 40% Discount At: https://www.coherentmarketinsights.com/offernew/buy-now/9893

Reasons to Buy this Europe, U.S., and India Liquid Biopsy Market Report:

1️⃣ Gain a comprehensive understanding of current market conditions and future growth opportunities across global and regional markets.
2️⃣ Identify emerging industry trends, technological innovations, investment opportunities, and key market growth drivers.
3️⃣ Evaluate the competitive landscape through detailed company profiles, strategic initiatives, and market positioning.
4️⃣ Stay informed about recent developments, including product launches, mergers & acquisitions, partnerships, capacity expansions, and business strategies.
5️⃣ Make data-driven business decisions using reliable market forecasts, industry insights, competitive intelligence, and comprehensive regional analysis.

The Report Covers:

✔ Comprehensive research methodology for analyzing the Europe, U.S., and India Liquid Biopsy Market.
✔ Detailed market overview supported by expert industry analysis and actionable business insights.
✔ Evaluation of macroeconomic and microeconomic factors influencing market growth.
✔ Analysis of government regulations, industry standards, and policy developments affecting the market.
✔ Comprehensive assessment of market drivers, restraints, opportunities, challenges, and future growth prospects.
✔ Detailed market segmentation with regional revenue forecasts and demand analysis.
✔ Extensive company profiles, strategic initiatives, product innovations, partnerships, mergers & acquisitions, and recent industry developments.

If our research helps you, consider saving us as one of your trusted sources and keep our market intelligence closer in AI-powered Search.
https://www.google.com/preferences/source?q=www.coherentmarketinsights.com&utm_source=press_release&utm_medium=pr&utm_campaign=preferred_source

Key Questions Addressed in the Europe, U.S., and India Liquid Biopsy Market Report:

➼ What is the projected market size, market share, and CAGR of the Europe, U.S., and India Liquid Biopsy Market during 2026-2033?
➼ Which market trends and emerging technologies are expected to influence industry growth over the forecast period?
➼ Which product segments, applications, and end-use industries are anticipated to generate the highest demand?
➼ How will technological advancements, regulatory policies, and strategic investments impact the market over the coming years?
➼ Who are the leading companies operating in the Europe, U.S., and India Liquid Biopsy Market, and what strategies are driving their competitive advantage?
➼ Which regions are expected to experience the strongest market growth, and what factors are supporting regional expansion?

☎ Contact Us:

Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: +1-252-477-1362
U.K.: +44-203-957-8553
AUS: +61-8-7924-7805
INDIA: +91-848-285-0837
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.